메뉴 건너뛰기




Volumn 73, Issue 12, 2013, Pages 3692-3703

Inhibition of c-met reduces lymphatic metastasis in RIP-Tag2 transgenic mice

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; PF 04217903; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

EID: 84879114193     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-2160     Document Type: Article
Times cited : (53)

References (60)
  • 1
    • 25444525461 scopus 로고    scopus 로고
    • Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
    • DOI 10.1038/nrc1693, PII N1693
    • Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005;5:735-43. (Pubitemid 41486366)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.9 , pp. 735-743
    • Cao, Y.1
  • 5
    • 26644471951 scopus 로고    scopus 로고
    • Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
    • DOI 10.1016/j.ccr.2005.09.005, PII S1535610805002989
    • Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005;8:299-309. (Pubitemid 41443415)
    • (2005) Cancer Cell , vol.8 , Issue.4 , pp. 299-309
    • Casanovas, O.1    Hicklin, D.J.2    Bergers, G.3    Hanahan, D.4
  • 7
    • 60649106195 scopus 로고    scopus 로고
    • Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
    • Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15: 220-31.
    • (2009) Cancer Cell , vol.15 , pp. 220-231
    • Paez-Ribes, M.1    Allen, E.2    Hudock, J.3    Takeda, T.4    Okuyama, H.5    Vinals, F.6
  • 8
    • 84863704553 scopus 로고    scopus 로고
    • Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors
    • Sennino B, Ishiguro-Oonuma T, Wei Y, Naylor RM, Williamson CW, Bhagwandin V, et al. Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discov 2012;2:1-18.
    • (2012) Cancer Discov , vol.2 , pp. 1-18
    • Sennino, B.1    Ishiguro-Oonuma, T.2    Wei, Y.3    Naylor, R.M.4    Williamson, C.W.5    Bhagwandin, V.6
  • 9
    • 0037478437 scopus 로고    scopus 로고
    • Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
    • DOI 10.1016/S1535-6108(03)00085-0, PII S1535610803000850
    • Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003;3:347-61. (Pubitemid 38340304)
    • (2003) Cancer Cell , vol.3 , Issue.4 , pp. 347-361
    • Pennacchietti, S.1    Michieli, P.2    Galluzzo, M.3    Mazzone, M.4    Giordano, S.5    Comoglio, P.M.6
  • 10
    • 34848855124 scopus 로고    scopus 로고
    • The MET receptor tyrosine kinase in invasion and metastasis
    • DOI 10.1002/jcp.21183
    • Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 2007;213:316-25. (Pubitemid 47509708)
    • (2007) Journal of Cellular Physiology , vol.213 , Issue.2 , pp. 316-325
    • Benvenuti, S.1    Comoglio, P.M.2
  • 11
    • 47949117458 scopus 로고    scopus 로고
    • Beyond VEGF: Targeting tumor growth and angiogenesis via alternative mechanisms
    • Christensen J, Anderes K. Beyond VEGF: targeting tumor growth and angiogenesis via alternative mechanisms. Adv ExpMed Biol 2008;610: 43-53.
    • (2008) Adv ExpMed Biol , vol.610 , pp. 43-53
    • Christensen, J.1    Anderes, K.2
  • 13
    • 69149089019 scopus 로고    scopus 로고
    • Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer
    • Graveel CR, DeGroot JD, Su Y, Koeman J, Dykema K, Leung S, et al. Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. Proc Natl Acad Sci U S A 2009;106: 12909-14.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 12909-12914
    • Graveel, C.R.1    DeGroot, J.D.2    Su, Y.3    Koeman, J.4    Dykema, K.5    Leung, S.6
  • 14
    • 0032523074 scopus 로고    scopus 로고
    • Expression of c-met is a strong independent prognostic factor in breast carcinoma
    • DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AI
    • Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer 1998;82:1513-20. (Pubitemid 28164998)
    • (1998) Cancer , vol.82 , Issue.8 , pp. 1513-1520
    • Ghoussoub, R.A.D.1    Dillon, D.A.2    D'Aquila, T.3    Rimm, E.B.4    Fearon, E.R.5    Rimm, D.L.6
  • 15
    • 58949099258 scopus 로고    scopus 로고
    • Prognostic significance of c-Met expression in glioblastomas
    • Kong DS, Song SY, Kim DH, Joo KM, Yoo JS, Koh JS, et al. Prognostic significance of c-Met expression in glioblastomas. Cancer 2009;115: 140-8.
    • (2009) Cancer , vol.115 , pp. 140-148
    • Kong, D.S.1    Song, S.Y.2    Kim, D.H.3    Joo, K.M.4    Yoo, J.S.5    Koh, J.S.6
  • 17
  • 18
    • 33646407806 scopus 로고    scopus 로고
    • Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action
    • Cao R, Bjorndahl MA, Gallego MI, Chen S, Religa P, Hansen AJ, et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 2006;107:3531-6.
    • (2006) Blood , vol.107 , pp. 3531-3536
    • Cao, R.1    Bjorndahl, M.A.2    Gallego, M.I.3    Chen, S.4    Religa, P.5    Hansen, A.J.6
  • 19
    • 30544452034 scopus 로고    scopus 로고
    • Hepatocyte growth factor promotes lymphatic vessel formation and function
    • DOI 10.1038/sj.emboj.7600763, PII 7600763
    • Kajiya K, Hirakawa S, Ma B, Drinnenberg I, Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005;24:2885-95. (Pubitemid 43079892)
    • (2005) EMBO Journal , vol.24 , Issue.16 , pp. 2885-2895
    • Kajiya, K.1    Hirakawa, S.2    Ma, B.3    Drinnenberg, I.4    Detmar, M.5
  • 20
    • 44849093414 scopus 로고    scopus 로고
    • A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities
    • Christensen JG. A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities. Ann Oncol 2007;18 Suppl 10:x3-10.
    • (2007) Ann Oncol , vol.18 , Issue.SUPPL. 10
    • Christensen, J.G.1
  • 21
    • 67049134253 scopus 로고    scopus 로고
    • Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors
    • Timofeevski SL, McTigue MA, Ryan K, Cui J, Zou HY, Zhu JX, et al. Enzymatic characterization of c-Met receptor tyrosine kinase oncogenic mutants and kinetic studies with aminopyridine and triazolopyrazine inhibitors. Biochemistry 2009;48:5339-49.
    • (2009) Biochemistry , vol.48 , pp. 5339-5349
    • Timofeevski, S.L.1    McTigue, M.A.2    Ryan, K.3    Cui, J.4    Zou, H.Y.5    Zhu, J.X.6
  • 22
    • 0021888904 scopus 로고
    • Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
    • DOI 10.1038/315115a0
    • Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenicmice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115-22. (Pubitemid 15064530)
    • (1985) Nature , vol.315 , Issue.6015 , pp. 115-122
    • Hanahan, D.1
  • 24
    • 33646917482 scopus 로고    scopus 로고
    • Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice
    • DOI 10.1016/j.jim.2006.01.022, PII S0022175906000640
    • Van den Broeck W, Derore A, Simoens P. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 2006;312: 12-9. (Pubitemid 43795993)
    • (2006) Journal of Immunological Methods , vol.312 , Issue.1-2 , pp. 12-19
    • Van Den, B.W.1    Derore, A.2    Simoens, P.3
  • 27
    • 44449138380 scopus 로고    scopus 로고
    • Markers for microscopic imaging of lymphangiogenesis and angiogenesis
    • DOI 10.1196/annals.1413.001
    • Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 2008;1131:1-12. (Pubitemid 351758499)
    • (2008) Annals of the New York Academy of Sciences , vol.1131 , pp. 1-12
    • Baluk, P.1    McDonald, D.M.2
  • 28
    • 0000391746 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    • Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
    • (2000) Nat Cell Biol , vol.2 , pp. 737-744
    • Bergers, G.1    Brekken, R.2    McMahon, G.3    Vu, T.H.4    Itoh, T.5    Tamaki, K.6
  • 29
    • 34047175559 scopus 로고    scopus 로고
    • Targeting VEGF-A to treat cancer and age-related macular degeneration
    • DOI 10.1146/annurev.med.58.061705.145635
    • Ferrara N, Mass RD, Campa C, Kim R. Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 2007;58:491-504. (Pubitemid 46706529)
    • (2007) Annual Review of Medicine , vol.58 , pp. 491-504
    • Ferrara, N.1    Mass, R.D.2    Campa, C.3    Kim, R.4
  • 30
    • 0034255151 scopus 로고    scopus 로고
    • Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases
    • DOI 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3
    • Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 2000;89:488-99. (Pubitemid 30640095)
    • (2000) Cancer , vol.89 , Issue.3 , pp. 488-499
    • Bruns, C.J.1    Liu, W.2    Davis, D.W.3    Shaheen, R.M.4    McConkey, D.J.5    Wilson, M.R.6    Bucana, C.D.7    Hicklin, D.J.8    Ellis, L.M.9
  • 32
  • 33
    • 26844481561 scopus 로고    scopus 로고
    • Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension
    • DOI 10.1210/en.2005-0416
    • Hayashi M, Sakata M, Takeda T, Tahara M, Yamamoto T, Okamoto Y, et al. Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1alpha is involved in trophoblast invasion under low-oxygen tension. Endocrinology 2005;146: 4682-9. (Pubitemid 41446605)
    • (2005) Endocrinology , vol.146 , Issue.11 , pp. 4682-4689
    • Hayashi, M.1    Sakata, M.2    Takeda, T.3    Tahara, M.4    Yamamoto, T.5    Okamoto, Y.6    Minekawa, R.7    Isobe, A.8    Ohmichi, M.9    Tasaka, K.10    Murata, Y.11
  • 34
    • 0344406080 scopus 로고    scopus 로고
    • Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region
    • Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003;63:1920-6. (Pubitemid 36460859)
    • (2003) Cancer Research , vol.63 , Issue.8 , pp. 1920-1926
    • Maula, S.-M.1    Luukkaa, M.2    Grenman, R.3    Jackson, D.4    Jalkanen, S.5    Ristamaki, R.6
  • 35
    • 74649086696 scopus 로고    scopus 로고
    • Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma
    • Lee K, Park do J, Choe G, Kim HH, Kim WH, Lee HS. Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol 2010;17:73-80.
    • (2010) Ann Surg Oncol , vol.17 , pp. 73-80
    • Lee, K.1    Park Do, J.2    Choe, G.3    Kim, H.H.4    Kim, W.H.5    Lee, H.S.6
  • 37
    • 17144402207 scopus 로고    scopus 로고
    • VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
    • DOI 10.1084/jem.20041896
    • Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005;201:1089-99. (Pubitemid 40524677)
    • (2005) Journal of Experimental Medicine , vol.201 , Issue.7 , pp. 1089-1099
    • Hirakawa, S.1    Kodama, S.2    Kunstfeld, R.3    Kajiya, K.4    Brown, L.F.5    Detmar, M.6
  • 38
    • 63749125392 scopus 로고    scopus 로고
    • VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
    • Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009;21:154-65.
    • (2009) Curr Opin Cell Biol , vol.21 , pp. 154-165
    • Lohela, M.1    Bry, M.2    Tammela, T.3    Alitalo, K.4
  • 39
    • 76749083490 scopus 로고    scopus 로고
    • Lymphangiogenesis: Molecular mechanisms and future promise
    • Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010;140:460-76.
    • (2010) Cell , vol.140 , pp. 460-476
    • Tammela, T.1    Alitalo, K.2
  • 40
    • 0033814892 scopus 로고    scopus 로고
    • VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues
    • Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000;14:2087-96.
    • (2000) FASEB J , vol.14 , pp. 2087-2096
    • Partanen, T.A.1    Arola, J.2    Saaristo, A.3    Jussila, L.4    Ora, A.5    Miettinen, M.6
  • 41
    • 33645046619 scopus 로고    scopus 로고
    • Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2
    • Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 2006;66:2650-7.
    • (2006) Cancer Res , vol.66 , pp. 2650-2657
    • Roberts, N.1    Kloos, B.2    Cassella, M.3    Podgrabinska, S.4    Persaud, K.5    Wu, Y.6
  • 42
    • 79959278619 scopus 로고    scopus 로고
    • Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3
    • Kodera Y, Katanasaka Y, Kitamura Y, Tsuda H, Nishio K, Tamura T, et al. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. Breast Cancer Res 2011; 13:R66.
    • (2011) Breast Cancer Res , vol.13
    • Kodera, Y.1    Katanasaka, Y.2    Kitamura, Y.3    Tsuda, H.4    Nishio, K.5    Tamura, T.6
  • 44
    • 84860591982 scopus 로고    scopus 로고
    • Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
    • Maione F, Capano S, Regano D, Zentilin L, Giacca M, Casanovas O, et al. Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J Clin Invest 2012;122:1832-48.
    • (2012) J Clin Invest , vol.122 , pp. 1832-1848
    • Maione, F.1    Capano, S.2    Regano, D.3    Zentilin, L.4    Giacca, M.5    Casanovas, O.6
  • 45
    • 84863715967 scopus 로고    scopus 로고
    • Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumor models
    • Singh M, Couto SS, Forrest WF, Lima A, Cheng JH, Molina R, et al. Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumor models. J Pathol 2012;227:417-30.
    • (2012) J Pathol , vol.227 , pp. 417-430
    • Singh, M.1    Couto, S.S.2    Forrest, W.F.3    Lima, A.4    Cheng, J.H.5    Molina, R.6
  • 46
    • 84863718886 scopus 로고    scopus 로고
    • Differential drug-class specific metastatic effects following treatment with a panel of angiogenesis inhibitors
    • Chung AS, Kowanetz M, Wu X, Zhuang G, Ngu H, Finkle D, et al. Differential drug-class specific metastatic effects following treatment with a panel of angiogenesis inhibitors. J Pathol 2012;227:404-16.
    • (2012) J Pathol , vol.227 , pp. 404-416
    • Chung, A.S.1    Kowanetz, M.2    Wu, X.3    Zhuang, G.4    Ngu, H.5    Finkle, D.6
  • 49
    • 37549059613 scopus 로고    scopus 로고
    • Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma
    • Christensen JG, Zou HY, Arango ME, Li Q, Lee JH, McDonnell SR, et al. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma. Mol Cancer Ther 2007;6:3314-22.
    • (2007) Mol Cancer Ther , vol.6 , pp. 3314-3322
    • Christensen, J.G.1    Zou, H.Y.2    Arango, M.E.3    Li, Q.4    Lee, J.H.5    McDonnell, S.R.6
  • 50
    • 49249100382 scopus 로고    scopus 로고
    • MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival
    • Jin H, Yang R, Zheng Z, Romero M, Ross J, Bou-Reslan H, et al. MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival. Cancer Res 2008; 68:4360-8.
    • (2008) Cancer Res , vol.68 , pp. 4360-4368
    • Jin, H.1    Yang, R.2    Zheng, Z.3    Romero, M.4    Ross, J.5    Bou-Reslan, H.6
  • 52
    • 83355166909 scopus 로고    scopus 로고
    • Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth
    • Yakes FM, Chen J, Tan J, Yamaguchi K, Shi Y, Yu P, et al. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. Mol Cancer Ther 2011;10:2298-308.
    • (2011) Mol Cancer Ther , vol.10 , pp. 2298-2308
    • Yakes, F.M.1    Chen, J.2    Tan, J.3    Yamaguchi, K.4    Shi, Y.5    Yu, P.6
  • 53
    • 80053571555 scopus 로고    scopus 로고
    • Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): Results from a phase II randomized discontinuation trial
    • abstr 4516
    • Hussain M, Smith MR, Sweeney C, Corn PG, Elfiky A, Gordon MS, et al. Cabozantinib (XL184) in metastatic castration-resistant prostate cancer (mCRPC): results from a phase II randomized discontinuation trial. J Clin Oncol. 29, 2011 (suppl; abstr 4516.
    • (2011) J Clin Oncol 29 , Issue.SUPPL.
    • Hussain, M.1    Smith, M.R.2    Sweeney, C.3    Corn, P.G.4    Elfiky, A.5    Gordon, M.S.6
  • 54
    • 84555190809 scopus 로고    scopus 로고
    • MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib
    • Lennerz JK, Kwak EL, Ackerman A, Michael M, Fox SB, Bergethon K, et al. MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. J Clin Oncol 2011;29:4803-10.
    • (2011) J Clin Oncol , vol.29 , pp. 4803-4810
    • Lennerz, J.K.1    Kwak, E.L.2    Ackerman, A.3    Michael, M.4    Fox, S.B.5    Bergethon, K.6
  • 55
    • 84864281453 scopus 로고    scopus 로고
    • Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence
    • Catenacci DV, Henderson L, Xiao SY, Patel P, Yauch RL, Hegde P, et al. Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence. Cancer Discov 2011;1:573-9.
    • (2011) Cancer Discov , vol.1 , pp. 573-579
    • Catenacci, D.V.1    Henderson, L.2    Xiao, S.Y.3    Patel, P.4    Yauch, R.L.5    Hegde, P.6
  • 57
    • 84873812285 scopus 로고    scopus 로고
    • Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer
    • Lee RJ, Smith MR. Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer. Cancer J 2013;19:90-8.
    • (2013) Cancer J , vol.19 , pp. 90-98
    • Lee, R.J.1    Smith, M.R.2
  • 58
    • 84872310356 scopus 로고    scopus 로고
    • Cabozantinib approved for advanced medullary thyroid cancer
    • Traynor K. Cabozantinib approved for advanced medullary thyroid cancer. Am J Health Syst Pharm 2013;70:88.
    • (2013) Am J Health Syst Pharm , vol.70 , pp. 88
    • Traynor, K.1
  • 59
    • 84871721240 scopus 로고    scopus 로고
    • Tivantinib for second-line treatment of advanced hepatocellular carcinoma: A randomised, placebo-controlled phase 2 study
    • Santoro A, Rimassa L, Borbath I, Daniele B, Salvagni S, Van Laethem JL, et al. Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol 2013;14:55-63.
    • (2013) Lancet Oncol , vol.14 , pp. 55-63
    • Santoro, A.1    Rimassa, L.2    Borbath, I.3    Daniele, B.4    Salvagni, S.5    Van Laethem, J.L.6
  • 60
    • 79960408937 scopus 로고    scopus 로고
    • VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer
    • You WK, Sennino B, Williamson CW, Falcon B, Hashizume H, Yao LC, et al. VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer. Cancer Res 2011;71:4758-68.
    • (2011) Cancer Res , vol.71 , pp. 4758-4768
    • You, W.K.1    Sennino, B.2    Williamson, C.W.3    Falcon, B.4    Hashizume, H.5    Yao, L.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.